Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Bioreactors industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product type trends
2.1.3 Cell trends
2.1.4 Molecule trends
2.1.5 Usage trends
2.1.6 End-use trends
2.1.7 Regional trends
Chapter 3 Bioreactors Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing pharmaceutical and biotechnology industry
3.3.1.2 Technological advancements in bioreactors
3.3.1.3 Growing focus on orphan drug development
3.3.1.4 Rising demand for personalized medicines
3.3.2 Industry pitfalls & challenges
3.3.2.1 Low capacity of single-use bioreactors
3.3.2.2 Concerns regarding extractables and/or leachables
3.4 Growth potential analysis
3.4.1 By product type
3.4.2 By cell
3.4.3 By molecule
3.4.4 By usage
3.4.5 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Canada
3.6.3 Europe
3.6.4 China
3.7 Technology landscape
3.7.1 Technology overview of single-use bioreactors
3.7.1.1 Wave-induced motion SUB
3.7.1.2 Single-use bubble column
3.7.1.3 Stirred SUB
3.8 Porter's analysis
3.8.1 Bargaining power of suppliers
3.8.2 Bargaining power of buyers
3.8.3 Threat of new entrants
3.8.4 Threat of substitutes
3.8.5 Industry rivalry
3.9 PESTEL analysis
3.9.1 Political
3.9.2 Economical
3.9.3 Social
3.9.4 Technological
3.9.5 Environmental
3.9.6 Legal
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 Engie Group
4.1.2 Thermo Fisher Scientific Inc.
4.1.3 Danaher Corporation
4.1.4 Merck KGaA
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Bioreactors Market, By Product Type
5.1 Key segment trends
5.2 Single-use
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Reusable
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Bioreactors Market, By Cell
6.1 Key segment trends
6.2 Mammalian cells
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Bacterial cells
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Yeast cells
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Bioreactors Market, By Molecule
7.1 Key segment trends
7.2 Monoclonal antibodies
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Vaccines
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Recombinant proteins
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Stem cells
7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 Gene therapy
7.6.1 Market size, by region, 2018 - 2032 (USD Million)
7.7 Others
7.7.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Bioreactors Market, By Usage
8.1 Key segment trends
8.2 Developmental, pre-clinical & clinical
8.2.1 Market size, by region, 2018 - 2032 (USD Million)
8.3 Commercial production
8.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 9 Bioreactors Market, By End-use
9.1 Key segment trends
9.2 R&D organizations
9.2.1 Market size, by region, 2018 - 2032 (USD Million)
9.3 Biopharma manufacturers
9.3.1 Market size, by region, 2018 - 2032 (USD Million)
9.4 Contract manufacturing organizations (CMOs)
9.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 10 Bioreactors Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 Market size, by country, 2018 - 2032 (USD Million)
10.2.2 Market size, by product type, 2018 - 2032 (USD Million)
10.2.3 Market size, by cell, 2018 - 2032 (USD Million)
10.2.4 Market size, by molecule, 2018 - 2032 (USD Million)
10.2.5 Market size, by usage, 2018 - 2032 (USD Million)
10.2.6 Market size, by end-use, 2018 - 2032 (USD Million)
10.2.7 U.S.
10.2.7.1 Market size, by product type, 2018 - 2032 (USD Million)
10.2.7.2 Market size, by cell, 2018 - 2032 (USD Million)
10.2.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.2.7.4 Market size, by usage, 2018 - 2032 (USD Million)
10.2.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.2.8 Canada
10.2.8.1 Market size, by product type, 2018 - 2032 (USD Million)
10.2.8.2 Market size, by cell, 2018 - 2032 (USD Million)
10.2.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.2.8.4 Market size, by usage, 2018 - 2032 (USD Million)
10.2.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3 Europe
10.3.1 Market size, by country, 2018 - 2032 (USD Million)
10.3.2 Market size, by product type, 2018 - 2032 (USD Million)
10.3.3 Market size, by cell, 2018 - 2032 (USD Million)
10.3.4 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.5 Market size, by usage, 2018 - 2032 (USD Million)
10.3.6 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.7 Germany
10.3.7.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.7.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.7.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.8 UK
10.3.8.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.8.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.8.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.9 France
10.3.9.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.9.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.9.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.9.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.9.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.10 Spain
10.3.10.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.10.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.10.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.10.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.10.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.11 Italy
10.3.11.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.11.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.11.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.11.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.11.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.12 The Netherlands
10.3.12.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.12.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.12.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.12.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.12.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.3.13 Denmark
10.3.13.1 Market size, by product type, 2018 - 2032 (USD Million)
10.3.13.2 Market size, by cell, 2018 - 2032 (USD Million)
10.3.13.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.3.13.4 Market size, by usage, 2018 - 2032 (USD Million)
10.3.13.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.4 Asia Pacific
10.4.1 Market size, by country, 2018 - 2032 (USD Million)
10.4.2 Market size, by product type, 2018 - 2032 (USD Million)
10.4.3 Market size, by cell, 2018 - 2032 (USD Million)
10.4.4 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.5 Market size, by usage, 2018 - 2032 (USD Million)
10.4.6 Market size, by end-use, 2018 - 2032 (USD Million)
10.4.7 China
10.4.7.1 Market size, by product type, 2018 - 2032 (USD Million)
10.4.7.2 Market size, by cell, 2018 - 2032 (USD Million)
10.4.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.7.4 Market size, by usage, 2018 - 2032 (USD Million)
10.4.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.4.8 Japan
10.4.8.1 Market size, by product type, 2018 - 2032 (USD Million)
10.4.8.2 Market size, by cell, 2018 - 2032 (USD Million)
10.4.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.8.4 Market size, by usage, 2018 - 2032 (USD Million)
10.4.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.4.9 India
10.4.9.1 Market size, by product type, 2018 - 2032 (USD Million)
10.4.9.2 Market size, by cell, 2018 - 2032 (USD Million)
10.4.9.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.9.4 Market size, by usage, 2018 - 2032 (USD Million)
10.4.9.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.4.10 South Korea
10.4.10.1 Market size, by product type, 2018 - 2032 (USD Million)
10.4.10.2 Market size, by cell, 2018 - 2032 (USD Million)
10.4.10.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.10.4 Market size, by usage, 2018 - 2032 (USD Million)
10.4.10.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.4.11 Australia
10.4.11.1 Market size, by product type, 2018 - 2032 (USD Million)
10.4.11.2 Market size, by cell, 2018 - 2032 (USD Million)
10.4.11.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.11.4 Market size, by usage, 2018 - 2032 (USD Million)
10.4.11.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.4.12 Singapore
10.4.12.1 Market size, by product type, 2018 - 2032 (USD Million)
10.4.12.2 Market size, by cell, 2018 - 2032 (USD Million)
10.4.12.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.4.12.4 Market size, by usage, 2018 - 2032 (USD Million)
10.4.12.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.5 Latin America
10.5.1 Market size, by country, 2018 - 2032 (USD Million)
10.5.2 Market size, by product type, 2018 - 2032 (USD Million)
10.5.3 Market size, by cell, 2018 - 2032 (USD Million)
10.5.4 Market size, by molecule, 2018 - 2032 (USD Million)
10.5.5 Market size, by usage, 2018 - 2032 (USD Million)
10.5.6 Market size, by end-use, 2018 - 2032 (USD Million)
10.5.7 Brazil
10.5.7.1 Market size, by product type, 2018 - 2032 (USD Million)
10.5.7.2 Market size, by cell, 2018 - 2032 (USD Million)
10.5.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.5.7.4 Market size, by usage, 2018 - 2032 (USD Million)
10.5.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.5.8 Mexico
10.5.8.1 Market size, by product type, 2018 - 2032 (USD Million)
10.5.8.2 Market size, by cell, 2018 - 2032 (USD Million)
10.5.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.5.8.4 Market size, by usage, 2018 - 2032 (USD Million)
10.5.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.6 Middle East & Africa
10.6.1 Market size, by country, 2018 - 2032 (USD Million)
10.6.2 Market size, by product type, 2018 - 2032 (USD Million)
10.6.3 Market size, by cell, 2018 - 2032 (USD Million)
10.6.4 Market size, by molecule, 2018 - 2032 (USD Million)
10.6.5 Market size, by usage, 2018 - 2032 (USD Million)
10.6.6 Market size, by end-use, 2018 - 2032 (USD Million)
10.6.7 South Africa
10.6.7.1 Market size, by product type, 2018 - 2032 (USD Million)
10.6.7.2 Market size, by cell, 2018 - 2032 (USD Million)
10.6.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.6.7.4 Market size, by usage, 2018 - 2032 (USD Million)
10.6.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
10.6.8 UAE
10.6.8.1 Market size, by product type, 2018 - 2032 (USD Million)
10.6.8.2 Market size, by cell, 2018 - 2032 (USD Million)
10.6.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
10.6.8.4 Market size, by usage, 2018 - 2032 (USD Million)
10.6.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 11 Company Profiles
11.1 Applikon Biotechnology, Inc. (Getinge)
11.1.1 Business overview
11.1.2 Financial data
11.1.3 Product landscape
11.1.4 Strategic outlook
11.1.5 SWOT analysis
11.2 Bbi Biotech
11.2.1 Business overview
11.2.2 Financial data
11.2.3 Product landscape
11.2.4 Strategic outlook
11.2.5 SWOT analysis
11.3 Cellexus Ltd
11.3.1 Business overview
11.3.2 Financial data
11.3.3 Product landscape
11.3.4 Strategic outlook
11.3.5 SWOT analysis
11.4 CerCell ApS
11.4.1 Business overview
11.4.2 Financial data
11.4.3 Product landscape
11.4.4 Strategic outlook
11.4.5 SWOT analysis
11.5 CESCO Bioengineering Co. Ltd.
11.5.1 Business overview
11.5.2 Financial data
11.5.3 Product landscape
11.5.4 Strategic outlook
11.5.5 SWOT analysis
11.6 Eppendorf AG
11.6.1 Business overview
11.6.2 Financial data
11.6.3 Product landscape
11.6.4 Strategic outlook
11.6.5 SWOT analysis
11.7 GEA Group Aktiengesellschaft
11.7.1 Business overview
11.7.2 Financial data
11.7.3 Product landscape
11.7.4 Strategic outlook
11.7.5 SWOT analysis
11.8 Merck Group
11.8.1 Business overview
11.8.2 Financial data
11.8.3 Product landscape
11.8.4 Strategic outlook
11.8.5 SWOT analysis
11.9 Danaher Corporation
11.9.1 Business overview
11.9.2 Financial data
11.9.3 Product landscape
11.9.4 Strategic outlook
11.9.5 SWOT analysis
11.10 PBS Biotech
11.10.1 Business overview
11.10.2 Financial data
11.10.3 Product landscape
11.10.4 Strategic outlook
11.10.5 SWOT analysis
11.11 Pierre Guerin Sas (Engie)
11.11.1 Business overview
11.11.2 Financial data
11.11.3 Product landscape
11.11.4 Strategic outlook
11.11.5 SWOT analysis
11.12 Sartorius Stedim Biotech Group
11.12.1 Business overview
11.12.2 Financial data
11.12.3 Product landscape
11.12.4 Strategic outlook
11.12.5 SWOT analysis
11.13 Shanghai Bailun Biotechnology Co. Ltd.,
11.13.1 Business overview
11.13.2 Financial data
11.13.3 Product landscape
11.13.4 Strategic outlook
11.13.5 SWOT analysis
11.14 Solaris Biotech Solutions
11.14.1 Business overview
11.14.2 Financial data
11.14.3 Product landscape
11.14.4 Strategic outlook
11.14.5 SWOT analysis
11.15 Thermo Fisher Scientific
11.15.1 Business overview
11.15.2 Financial data
11.15.3 Product landscape
11.15.4 Strategic outlook
11.15.5 SWOT analysis
